483
Shaji K. Kumar, M.D.FDA 483 - Shaji K. Kumar, M.D. - June 20, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Mayo Clinic in Rochester, MN, identified significant issues related to the conduct of an investigational study. Observations included failures to adhere to the investigational plan and protocols, specifically regarding the capture and reporting of serious adverse events. Additionally, the firm failed to retain required investigational records for the specified period, with numerous source documents found missing.
Open in Dashboard
ID · 6e773248-3139-4cda-8488-f1307304e820